Table 1 Selected pretreatment characteristics of the analyzed study population
From: Side effects during chemotherapy predict tumour response in advanced colorectal cancer
No of patients, n (%) | ||
|---|---|---|
Gender | ||
Male | 190 | 63% |
Female | 113 | 37% |
Age | ||
Median | 66.5 | |
Range | 38–79 | |
WHO performance status | ||
0 | 138 | 46% |
1 | 123 | 40% |
2 | 42 | 14% |
Primary site | ||
Colon | 193 | 64% |
Rectum | 110 | 36% |
Sites of metastases | ||
Liver | 218 | |
Lung | 75 | |
Abdominopelvic mass | 99 | |
Other | 118 | |
Number of metastatic sites | ||
Single | 116 | 38% |
Multiple | 187 | 62% |
